J&J/Guidant To Divest Peripheral Devices To Meet EC Competition Rules
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson has agreed to divest Guidant's European peripheral stent business as a condition of the European Commission's approval of the planned acquisition